-
Bortezomib combined with low-dose cytarabine in Intermediate-2 and high risk ...
International audience -
Intrathecal liposomal cytarabine (lipoCIT) administration in patients with le...
International audience -
Minimally differentiated acute myeloid leukemia (FAB AML-M0): prognostic fact...
International audience -
Sensitivity and gene expression profile of fresh human acute myeloid leukemia...
International audience -
Addition of lomustine to idarubicin and cytarabine improves the outcome of el...
International audience
